Updated on 12 September 2014
Dr Nirupama (Rupa) Shevde, customer training manager, life sciences solutions group, Thermo Fisher Scientific
Singapore: South Korea has made strong advancement in stem cell research, through government support and efforts of academy and industry. It is among the few countries producing stem cells and commercializing stem cell drugs.
Pharmicell is commercializing Hearticellgram for acute myocardial infarction, Dong A Pharma has developed Cartistem for knee cartilage injury and Anterogen has developed Cupistem for Crohn's disease.
To promote advances made by stem cell researchers and professionals, . Around 60 scientists from universities involved in research in medicine and health care as well as professional researchers from private companies attended the session at Thermo Fisher Scientific Suseo location in Seoul.
Dr Shevde is a global customer training manager in Life Sciences solutions group at Thermo Fisher Scientific. She has extensive experience in both mouse and human pluripotent stem cell research and has served as a senior scientist and director of education at WiCell Research Institute and Morgridge Institute for Research since 2005 until July 2012. Under the scientific leadership of human embryonic stem cell pioneer, Dr James Thomson, Rupa has developed a Stem Cell Training Course which has served over 800 scientists from 32 US states and 20 countries. Dr Shevde has worked with Dr Thomson's laboratory and gained expertise in the novel Essential 8 Medium, Vitronectin (VTN-N) substrate and non-integrating episomal reprogramming technology developed by Dr James Thomson and marketed by Life Technologies.
In an interview with BioSpectrum Asia, Dr Shevde shares her thought and experience on stem cell research landscape in Korea and how the country is building its capacity to excel in this field.
What has been your experience while conducting workshop for Korea stem cell researchers and how is Korea progressing in building stem cell research capacity?
For more than a decade, we have provided stem cell scientists around the world with technologies and products to address challenges in stem cell research. With our complete portfolio of stem cell products and services, we believe that we can contribute to maximize the research and application of stem cells in South Korea with workshops like this.